Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

March 19, 2024 updated by: Kantonsspital Winterthur KSW
The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Within the framework of interdisciplinary cooperation for a sarcoma problem, predictive and prognostic criteria will be developed that improve the treatment and particularly outcome.

The outcome variables include patient characteristics, tumor types and characteristics, histology, management and treatment strategies as well as recurrence rate and overall survival.

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Switzerland
      • Lucerne, Switzerland, 6000
        • Recruiting
        • Luzerner Kantonsspital
        • Contact:
          • Gabriela Studer, Prof. Dr. med.
          • Phone Number: +41 41 205 58 01
      • Zürich, Switzerland, 8005
        • Recruiting
        • Pathologie Institut Enge
        • Contact:
          • Beata Bode, Prof. Dr. med.
          • Phone Number: +41 44 287 38 38
      • Zürich, Switzerland, 8032
      • Zürich, Switzerland, 8063
        • Recruiting
        • Stadtspital Zürich Triemli
        • Contact:
          • Markus Weber, Prof. Dr. med. Dr. h.c.
          • Phone Number: +41 44 416 43 01
    • Graubünden
      • Chur, Graubünden, Switzerland, 7000
        • Recruiting
        • Kantonsspital Graubünden
        • Contact:
          • Christian Michelitsch, Dr. med.
          • Phone Number: +41 81 256 62 05
    • Tessin
      • Bellinzona, Tessin, Switzerland, 6500
        • Recruiting
        • Ente Ospedaliero Cantonale
        • Contact:
          • Silke Gillessen Sommer, Prof. Dr. med.
          • Phone Number: +41 91 811 94 10
    • Zuerich
      • Winterthur, Zuerich, Switzerland, 8400
        • Recruiting
        • Kantonsspital Winterthur
        • Contact:
          • Stefan Breitenstein, Prof. Dr. med.
          • Phone Number: +41 52 266 2121
        • Contact:
    • Zürich
      • Winterthur, Zürich, Switzerland, 8400
        • Recruiting
        • SwissSarcomaNetwork
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients suffering from bone or soft tissue tumors.

Description

Inclusion Criteria:

  • Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN
  • Female and male subjects of all ages

Exclusion Criteria:

  • Documented objection of subsequent use of personal health data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnosis,
Time Frame: 5 years
Data collected in the registry will be evaluated and analyzed to determine criteria to improve treatment strategies
5 years
Local recurrence,
Time Frame: 5 years
s.o.
5 years
distant metastasis,
Time Frame: 5 years
s.o.
5 years
biopsy taken by operating surgeon-radiologist-team,
Time Frame: 5 years
s.o.
5 years
pathology centrally reviewed,
Time Frame: 5 years
s.o.
5 years
Surgery (yes/no),
Time Frame: 5 years
s.o.
5 years
Surgical margin status,
Time Frame: 5 years
s.o.
5 years
surgery performed by dedicated surgeon,
Time Frame: 5 years
s.o.
5 years
Radiation Therapy (yes/no),
Time Frame: 5 years
s.o.
5 years
Chemotherapy (yes/no),
Time Frame: 5 years
s.o.
5 years
decision of board carried out,
Time Frame: 5 years
s.o.
5 years
Status at last contact,
Time Frame: 5 years
s.o.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kantonsspital Winterthur KSW

Collaborators

Swiss Sarcoma Network

Investigators

  • Principal Investigator: Bruno Fuchs, Prof, SwissSarcomaNetwork

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2019

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

February 20, 2020

First Submitted That Met QC Criteria

March 5, 2020

First Posted (Actual)

March 9, 2020

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-01107

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcoma

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe